Continuous infusion instead of bolus injections of factor concentrate?

Haemophilia

Volumn 2, Issue 4, 1996, Pages 189-191

  Schulman, S ^a   Martinowitz, U ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; LIPOSOME;

BLEEDING; BOLUS INJECTION; CENTRAL VENOUS CATHETERIZATION; CONTINUOUS INFUSION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG STABILITY; HEALTH CARE COST; HEMOPHILIA; HEMOSTASIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029798592     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.1996.tb00134.x     Document Type: Short Survey

References (16)

1. Schulman S. DDAVP - the multipotent drug in patients with coagulopathies. Trans Med Rev, 1991; 5: 132-44.
2. Gerrard AJ, Austen DEG, Brownlee GG. Subcutaneous injection of factor IX for the treatment of haemophilia B. Br J Haematol, 1992; 81: 610-3.
3. Berrettini M, Iorio P, Nenci GG, Arcieri P, Mariani G. Subcutaneous factor IX administration to patients with hemophilia B. Am J Hematol, 1994; 47: 61-2.
4. Lindley CM, Sawyer WT, Macik BG, et al. Pharmacokinetics and pharmacodynamics of recombinant factor Vila. Clin Pharmacol Ther 1994; 55: 638-48.
5. Schulman S, Varon D, Keller N, Giltel S, Martinowitz U. Monoclonal purified F VIII for continuous infusion: Stability, microbiological safety and clinical experience. Thromb Haemostas, 1994; 72: 403-7.
6. Varon D, Schulman S, Beshari D, Martinowitz U. Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage.
7. Gordon EM, Mungo R, Goldsmith JC. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Am J Pediatr Hematol Oncol, 1993; 15: 107-10.
8. Hermens WTH. Dose calculation of human factor VIII factor IX concentrates for infusion therapy. In: Brinkhouse KM, Hemker HC, eds. Handbook of Hemophilia, part II. New York: America Elsevier Publishing Co., 1975; 569-589.
9. Martinowitz U, Schulman S, Gitel S, Horoszowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol, 1992; 82: 729-34.
10. Schulman S, Gitel S, Zivelin A, et al. The feasibility of using concentrates containing factor IX for continuous infusion. Haemophilia, 1995; 1: 103-10.
11. Schulman S, Bech Jensen M, Varon D, et al. Feasibility of using recombinant factor Vila in continuous infusion. Thromb Haemostas.
12. Martinowitz, U, Schulman S. Continuous infusion of coagulation products. Int J Pediatr Hematol Oncol, 1994; 1: 471-8.
13. Schulman S, Gitel S, Martinowitz U. The stability of factor VIII concentrates after reconstitution. Am J Hematol, 1994; 45: 217-23.
14. Martinowitz U, Schulman S. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options? Blood Coag Fibrinol, 1996; 6 (Suppl 1): in press.
15. Gribble TJ, Jones JE, Chapelle JA, Vaughan LJ, Friedman KD. Continuous infusion of factor VIII as part of an immune tolerance induction program. Thromb Haemostas, 1995; 73: 1024 (abstract).
16. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J. Intern Med, 1992; 232: 25-32.